Reproducibility study of the pharmacokinetics of amikacin, gentamicin and tobramycin; a three-way crossover study

A. Dyas, R. Wise*, J. Pijck, Th Hallynck, J. Acar, D. Adam, R. Cadorniga, M. Wenk, H. H. Soep

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

The hypothesis that the pharmacokinetics of amikacin are more predictable than those of gentamicin or tobramycin was studied.In a three-way crossover design 58 volunteers received 7.5 mg/kg amikacin by iv infusion and either 1.5 mg/kg or 1 mg/kg gentamicin and tobramycin. The mean half-life and mean serum concentration at 1 h for each drug was determined. No consistent significant difference was found between the pharmacokinetics of amikacin and the other two drugs.

Original languageEnglish
Pages (from-to)371-376
Number of pages6
JournalJournal of Antimicrobial Chemotherapy
Volume12
Issue number4
DOIs
Publication statusPublished - Oct 1983
Externally publishedYes

Fingerprint

Dive into the research topics of 'Reproducibility study of the pharmacokinetics of amikacin, gentamicin and tobramycin; a three-way crossover study'. Together they form a unique fingerprint.

Cite this